We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$42.5B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+8.46%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$41.7B
AUM Growth
+$1.46B
(+3.6%)
Cap. Flow
-$623M
Cap. Flow
% of AUM
-1.49%
Top 10 Holdings %
Top 10 Hldgs %
43.34%
Holding
316
New
5
Increased
58
Reduced
137
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$174M |
| 2 |
AstraZeneca
AZN
|
+$166M |
| 3 |
Philip Morris
PM
|
+$134M |
| 4 |
NVIDIA
NVDA
|
+$91.4M |
| 5 |
Eaton
ETN
|
+$58.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$226M |
| 2 |
Union Pacific
UNP
|
+$93.1M |
| 3 |
PepsiCo
PEP
|
+$91.1M |
| 4 |
Microsoft
MSFT
|
+$63.4M |
| 5 |
Coca-Cola
KO
|
+$52.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.18% |
| 2 | Financials | 18.67% |
| 3 | Consumer Staples | 12.1% |
| 4 | Healthcare | 9.33% |
| 5 | Consumer Discretionary | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Organon & Co
OGN
$3.58B
| $205K | ﹤0.01% |
21,178
-130
| -0.6% | -$1.34K |
|
302
Arthur J. Gallagher & Co
AJG
$64.9B
| $203K | ﹤0.01% |
634
| – | – |
|
303
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47B
| $202K | ﹤0.01% |
2,200
| – | – |
|
304
American International
AIG
$39.9B
| $200K | ﹤0.01% |
2,339
-175
| -7% | -$14.6K |
|
305
HP
HPQ
$30.7B
| $200K | ﹤0.01% |
8,180
| – | – |
|
306
Orion Group Holdings
ORN
$365M
| $178K | ﹤0.01% |
19,674
| – | – |
|
|
ONTF
307
DELISTED
ON24
ONTF
| $89.2K | ﹤0.01% |
16,428
| – | – |
|
308
Nautilus Biotechnolgy
NAUT
$115M
| $32.6K | ﹤0.01% |
45,000
| – | – |
|
309
Becton Dickinson
BDX
$49.8B
| – | – |
-1,051
| Closed | -$241K |
|
310
Bristol-Myers Squibb
BMY
$131B
| – | – |
-3,930
| Closed | -$240K |
|
311
CenterPoint Energy
CNP
$25.5B
| – | – |
-100,766
| Closed | -$3.65M |
|
312
Dow Inc
DOW
$20.9B
| – | – |
-7,677
| Closed | -$268K |
|
313
EQT Corp
EQT
$33.3B
| – | – |
-4,107
| Closed | -$219K |
|
314
Howard Hughes
HHH
$3.64B
| – | – |
-2,931
| Closed | -$217K |
|
315
iShares Russell 1000 ETF
IWB
$48.7B
| – | – |
-1,344
| Closed | -$413K |
|
316
Rio Tinto
RIO
$159B
| – | – |
-3,411
| Closed | -$205K |
|
Similar funds
PCH
GAM
Fayez Sarofim & Co's Q2 2025 Portfolio in Review
As of Q2 2025, Fayez Sarofim & Co held 316 positions worth $41.7B, up 3.6% from $40.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.1%. Fayez Sarofim & Co opened 5 new positions and exited 8, leaving the 316-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Staples.
- Fayez Sarofim & Co's largest Q2 2025 buy was Schwab US Dividend Equity ETF: 820,000 shares worth $21.7M.
- Fayez Sarofim & Co added most to Meta Platforms (Facebook) in Q2 2025, an estimated $174M increase.
- Fayez Sarofim & Co's biggest Q2 2025 reduction was Apple, cutting an estimated $226M.
- Fayez Sarofim & Co fully exited CenterPoint Energy in Q2 2025, selling an estimated $3.65M.
- Fayez Sarofim & Co's ten largest holdings make up 43% of its $41.7B portfolio in Q2 2025.
- Fayez Sarofim & Co opened 5 new positions and closed 8 in Q2 2025.
- Fayez Sarofim & Co's portfolio value rose 3.6% quarter-over-quarter to $41.7B.
Based on Fayez Sarofim & Co's 13F filing for Q2 2025, filed 14 Aug 2025.